Does hepatitis B surface antigen kinetics, including both decline and reaching a threshold, improve prediction of response?
Johannes Wiegand, Keyur Patel, Hans L. Tillmann – 28 September 2009
Johannes Wiegand, Keyur Patel, Hans L. Tillmann – 28 September 2009
Hayato Hikita, Tetsuo Takehara, Satoshi Shimizu, Takahiro Kodama, Wei Li, Takuya Miyagi, Atsushi Hosui, Hisashi Ishida, Kazuyoshi Ohkawa, Tatsuya Kanto, Naoki Hiramatsu, Xiao‐Ming Yin, Lothar Hennighausen, Tomohide Tatsumi, Norio Hayashi – 28 September 2009 – Anti‐apoptotic members of the Bcl‐2 family, including Bcl‐2, Bcl‐xL, Mcl‐1, Bcl‐w and Bfl‐1, inhibit the mitochondrial pathway of apoptosis. Bcl‐xL and Mcl‐1 are constitutively expressed in the liver.
Alexander L. Gerbes, Dieter Jüngst – 28 September 2009
David R. Nelson – 28 September 2009
Kang Cheng, Daniel Benten, Kuldeep Bhargava, Mari Inada, Brigid Joseph, Christopher Palestro, Sanjeev Gupta – 28 September 2009 – Tracking stem/progenitor cells through noninvasive imaging is a helpful means of assessing the targeting of transplanted cells to specific organs. We performed in vitro and in vivo studies wherein adult human hepatocytes and human fetal liver stem/progenitor cells were labeled with indium‐111 (111In)‐oxine and technetium‐99m (99mTc)‐Ultratag or 99mTc‐Ceretec.
Xinqin Kang, Wei Zhong, Jie Liu, Zhenyuan Song, Craig J. McClain, Y. James Kang, Zhanxiang Zhou – 28 September 2009 – Alcoholic steatosis is a fundamental metabolic disorder in the progression of alcoholic liver disease. Zinc deficiency is one of the most consistently observed biochemical/nutritional manifestations of alcoholic liver disease. The purpose of this study is to determine whether dietary zinc supplementation to mice previously exposed to alcohol could reverse alcoholic steatosis.
Jordi Rimola, Alejandro Forner, Carmen Ayuso, Jordi Bruix, BCLC Group – 28 September 2009
Shujuan Pan, Richard N. Sifers – 28 September 2009
Jayant A. Talwalkar – 28 September 2009
Tetsuji Fujita – 28 September 2009